Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

AI-Driven Bioengineering Platforms Revolutionize Protein, Strain, and Drug Design with Multi-Billion Dollar Government Support

globenewswire.com
DNA The article mentions Ginkgo Bioworks in the context of the growing AI-driven bioengineering sector, highlighting its revenue. The sentiment is neutral as it's presented as an example within a larger market trend without specific positive or negative commentary. RXRX Recursion Pharmaceuticals is mentioned as a company in the AI-driven bioengineering sector, with its revenue cited. The sentiment is neutral as it's included as an example of market activity without specific positive or negative indicators.

Ottawa, Feb. 09, 2026 (GLOBE NEWSWIRE) -- According to data published by Precedence Research, the AI-driven bioengineering sector features companies like Ginkgo Bioworks ($478M revenue), Generate Biomedicines ($700M funding), and Recursion Pharmaceuticals ($261M revenue), designing millions of proteins and strains daily, screening over 15 billion compounds via AI, and training models on hundreds of millions of protein structures. Government programs in the USA, EU, UK, China, and Japan provide multi-billion-dollar funding, accelerating AI-enabled bioengineering innovation.

The AI-driven bioengineering market is transforming life sciences with high-throughput protein, strain, and compound design platforms, supported by hundreds of millions to billions in global funding, data published by Precedence Research.

Invest in Our Premium Strategic Solution: https://www.precedenceresearch.com/request-consultation/42

Key Company Insights

Platform Throughput & Compute

Government & Public Sector Funding

Market Insights

How Precedence Research Can Help

Precedence Research delivers actionable insights and quantitative intelligence for AI-driven bioengineering:

Contact Us:

Email: sales@precedenceresearch.com

USA: +1 8044 419344 | APAC: +61 4859 81310 / +91 87933 22019 | Europe: +44 7383 092 044

Precedence Research – Transforming AI and Bioengineering Data into Strategic Decisions